Cargando…

Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin

The ocular surface microbiome of veterinary species has not been thoroughly characterized using molecular-based techniques, such as next generation sequencing (NGS), as the vast majority of studies have utilized traditional culture-based techniques. To date, there is one pilot study evaluating the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Callie M., Scott, Erin M., Sarawichitr, Benjamin, Arnold, Carolyn, Suchodolski, Jan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282667/
https://www.ncbi.nlm.nih.gov/pubmed/32516320
http://dx.doi.org/10.1371/journal.pone.0234313
_version_ 1783544163010084864
author Rogers, Callie M.
Scott, Erin M.
Sarawichitr, Benjamin
Arnold, Carolyn
Suchodolski, Jan S.
author_facet Rogers, Callie M.
Scott, Erin M.
Sarawichitr, Benjamin
Arnold, Carolyn
Suchodolski, Jan S.
author_sort Rogers, Callie M.
collection PubMed
description The ocular surface microbiome of veterinary species has not been thoroughly characterized using molecular-based techniques, such as next generation sequencing (NGS), as the vast majority of studies have utilized traditional culture-based techniques. To date, there is one pilot study evaluating the ocular surface of healthy dogs using NGS. Furthermore, alterations in the ocular surface microbiome over time and after topical antibiotic treatment are unknown. The objectives of this study were to describe the bacterial composition of the ocular surface microbiome in clinically normal dogs, and to determine if microbial community changes occur over time or following topical antibiotic therapy. Topical neomycin-polymyxin-bacitracin ophthalmic ointment was applied to one eye each of 13 adult dogs three times daily for seven days, while contralateral eyes served as untreated controls. The inferior conjunctival fornix of both eyes was sampled via swabbing at baseline prior to antibiotic therapy (day 0), after 1 week of treatment (day 7), and 4 weeks after discontinuing treatment (day 35). Genomic DNA was extracted from the conjunctival swabs and primers targeting the V4 region of bacterial 16S rRNA genes were used to generate amplicon libraries, which were then sequenced on an Illumina platform. Data were analyzed using Quantitative Insights Into Molecular Ecology (QIIME 2.0). At baseline, the most relatively abundant phyla sequenced were Proteobacteria (49.7%), Actinobacteria (25.5%), Firmicutes (12%), Bacteroidetes (7.5%), and Fusobacteria (1.4%). The most common families detected were Pseudomonadaceae (13.2%), Micrococcaceae (12%), Pasteurellaceae (6.9%), Microbacteriaceae (5.2%), Enterobacteriaceae (3.9%), Neisseriaceae (3.5%), and Corynebacteriaceae (3.3%). Alpha and beta diversity measurements did not differ in both control and treatment eyes over time. This report examines the temporal stability of the canine ocular surface microbiome. The major bacterial taxa on the canine ocular surface remained consistent over time and following topical antibiotic therapy.
format Online
Article
Text
id pubmed-7282667
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-72826672020-06-17 Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin Rogers, Callie M. Scott, Erin M. Sarawichitr, Benjamin Arnold, Carolyn Suchodolski, Jan S. PLoS One Research Article The ocular surface microbiome of veterinary species has not been thoroughly characterized using molecular-based techniques, such as next generation sequencing (NGS), as the vast majority of studies have utilized traditional culture-based techniques. To date, there is one pilot study evaluating the ocular surface of healthy dogs using NGS. Furthermore, alterations in the ocular surface microbiome over time and after topical antibiotic treatment are unknown. The objectives of this study were to describe the bacterial composition of the ocular surface microbiome in clinically normal dogs, and to determine if microbial community changes occur over time or following topical antibiotic therapy. Topical neomycin-polymyxin-bacitracin ophthalmic ointment was applied to one eye each of 13 adult dogs three times daily for seven days, while contralateral eyes served as untreated controls. The inferior conjunctival fornix of both eyes was sampled via swabbing at baseline prior to antibiotic therapy (day 0), after 1 week of treatment (day 7), and 4 weeks after discontinuing treatment (day 35). Genomic DNA was extracted from the conjunctival swabs and primers targeting the V4 region of bacterial 16S rRNA genes were used to generate amplicon libraries, which were then sequenced on an Illumina platform. Data were analyzed using Quantitative Insights Into Molecular Ecology (QIIME 2.0). At baseline, the most relatively abundant phyla sequenced were Proteobacteria (49.7%), Actinobacteria (25.5%), Firmicutes (12%), Bacteroidetes (7.5%), and Fusobacteria (1.4%). The most common families detected were Pseudomonadaceae (13.2%), Micrococcaceae (12%), Pasteurellaceae (6.9%), Microbacteriaceae (5.2%), Enterobacteriaceae (3.9%), Neisseriaceae (3.5%), and Corynebacteriaceae (3.3%). Alpha and beta diversity measurements did not differ in both control and treatment eyes over time. This report examines the temporal stability of the canine ocular surface microbiome. The major bacterial taxa on the canine ocular surface remained consistent over time and following topical antibiotic therapy. Public Library of Science 2020-06-09 /pmc/articles/PMC7282667/ /pubmed/32516320 http://dx.doi.org/10.1371/journal.pone.0234313 Text en © 2020 Rogers et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rogers, Callie M.
Scott, Erin M.
Sarawichitr, Benjamin
Arnold, Carolyn
Suchodolski, Jan S.
Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin
title Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin
title_full Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin
title_fullStr Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin
title_full_unstemmed Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin
title_short Evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin
title_sort evaluation of the bacterial ocular surface microbiome in ophthalmologically normal dogs prior to and following treatment with topical neomycin-polymyxin-bacitracin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282667/
https://www.ncbi.nlm.nih.gov/pubmed/32516320
http://dx.doi.org/10.1371/journal.pone.0234313
work_keys_str_mv AT rogerscalliem evaluationofthebacterialocularsurfacemicrobiomeinophthalmologicallynormaldogspriortoandfollowingtreatmentwithtopicalneomycinpolymyxinbacitracin
AT scotterinm evaluationofthebacterialocularsurfacemicrobiomeinophthalmologicallynormaldogspriortoandfollowingtreatmentwithtopicalneomycinpolymyxinbacitracin
AT sarawichitrbenjamin evaluationofthebacterialocularsurfacemicrobiomeinophthalmologicallynormaldogspriortoandfollowingtreatmentwithtopicalneomycinpolymyxinbacitracin
AT arnoldcarolyn evaluationofthebacterialocularsurfacemicrobiomeinophthalmologicallynormaldogspriortoandfollowingtreatmentwithtopicalneomycinpolymyxinbacitracin
AT suchodolskijans evaluationofthebacterialocularsurfacemicrobiomeinophthalmologicallynormaldogspriortoandfollowingtreatmentwithtopicalneomycinpolymyxinbacitracin